The sex reassignment surgery market size in US to grow at a CAGR of 10.84% from 2022 to 2027 | The rising awareness among the transgender population to be a major trend -Technavio
NEW YORK, Aug. 4, 2023 /PRNewswire/ -- The sex reassignment surgery market in US is to grow by USD 125.78 million at a CAGR of 10.84% from 2023 to 2027, according to the latest research report from Technavio. Discover pharmaceutical industry potential and make informed business decisions based on qualitative and quantitative evidence highlighted in Technavio reports. view sample report!
The sex reassignment surgery market in US covers the following areas:
The sex reassignment surgery market in US is fragmented and companies are deploying organic and inorganic growth strategies to compete in the market.
Company Offering
Moein Surgical Arts - The company offers sex reassignment surgery such as male-to-female gender reassignment surgery.
Cedars Sinai health system - The company offers sex reassignment surgery such as bilateral orchiectomy.
Moein surgical arts - The company offers sex reassignment surgery such as male-to-female gender reassignment surgery.
For the market's companylandscape highlights with a comprehensive list of companies and their offerings - view samples in minutes
Key Market Segmentation
The market is segmented by type (male to female and female to male), and end-user (hospitals and clinics).
The market share growth by the male-to-female segment will be significant during the forecast period. Male-to-female sex reassignment surgery refers to the reshaping of the male genitals into a form that has the appearance of, and to some extent, the function of female genitalia. To appear more feminine, patients are subjected to female hormone therapy before surgery. Some of the associated surgeries that patients may opt to undergo other than basic surgery include vaginoplasty, facial hair removal, breast augmentation, facial feminization surgery, and various other procedures. Hence, these factors are expected to drive segment growth during the forecast period.
The increase in the number of people opting for sex change surgeries in the US is a key factor driving market growth. The number of transgender surgeries performed in the US each year ranges between 100 and 500. According to 2020 plastic surgery statistics provided by ASPS, transgender women have undergone 6,368 gender confirmation surgeries in the US, up from 5,616 in 2019. Additionally, 1,231 genital surgeries, 4,035 thoracoscopic or thoracic surgeries, and 1,102 facial surgeries were implemented in 2020. Hence, the increase in the number of people opting for sex change surgeries is expected to drive market growth during the forecast period.
Major Trends
The rising awareness among the transgender population about sex reassignment surgeries is a major trend in the market. This is due to the increasing visibility, improved social understanding, and acceptance of transgender people driven by the advent of social networks. Transgender people, therefore, have the freedom to choose to change sex through fertility counseling to explore their options, which may involve preserving fertility, such as cryopreservation. sperm or egg cells. In addition, the patients can also explore their gender identity, address the negative impact of gender dysphoria in their lives, and promote resilience with the help of counseling services that are offered in the market. Therefore, these factors are expected to drive market growth during the forecast period.
Side effects of sex reassignment surgeries are a significant challenge restricting market growth. Male-to-female sex change surgery is the reshaping of the male genitals into a shape that has the shape and to some extent function of the female genitals. Furthermore, before surgery, patients are treated with female hormones to look more feminine. Vaginoplasty, facial hair removal, breast augmentation, and facial feminization is some of the related surgeries that a patient may choose to perform in addition to the basic surgery. Hence, these factors are expected to restrict market growth during the forecast period.
The photodynamic therapy market is estimated to grow by USD 2,053.68 million at a CAGR of 8.22% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by application (cancer, actinic keratosis, psoriasis, acne, and others), product (photosensitizer drugs, and photodynamic therapy devices), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). Early detection of cancer is a key factor driving market growth during the forecast period.
The hereditary angioedema (HAE) therapeutics market is estimated to grow by USD 1,647.38 million at a CAGR of 8.95% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by end-user (hospital pharmacies, retail pharmacies, and e-commerce), product (C1-esterase inhibitor, bradykinin B2 receptor antagonist, kallikrein inhibitor, and others), geography (North America, Europe, Asia, and the Rest of the World (ROW)). The growing demand for personalized medicine is a major trend in the market.
Sex Reassignment Surgery Market Scope in US
Report Coverage
Details
Base year
2022
Historic period
2017-2021
Forecast period
2023-2027
Growth momentum & CAGR
Accelerate at a CAGR of 10.84%
Market growth 2023-2027
USD 125.78 million
Market structure
Fragmented
YoY growth 2022-2023(%)
8.63
Competitive landscape
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
Key companies profiled
Boston Children Hospital, Boston Medical Center, Cedars Sinai Health System, CNY Cosmetic and Reconstructive Surgery, Cornell University, Denver Health, Harvard University, Icahn School of Medicine at Mount Sinai, Mass General Brigham Inc., Moein Surgical Arts, Northwestern University, Oregon Health, and Science University, Plastic Surgery Group of Rochester, Regents of the University of Michigan, Stanford University, The Cleveland Clinic Foundation, The Johns Hopkins Health System Corp., The Regents of the University of California, The University of Utah, and Transgender Surgery Institute
Market dynamics
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Table of Contents
1 Executive Summary
1.1 Market Overview
Exhibit 01: Executive Summary ? Chart on Market Overview
Exhibit 02: Executive Summary ? Data Table on Market Overview
Exhibit 03: Executive Summary ? Chart of Country Market Characteristics
Exhibit 04: Executive Summary ? Chart on Market Segmentation by Type
Exhibit 05: Executive Summary ? Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary ? Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 07: Parent market
Exhibit 08: Market Characteristics
3 Market Sizing
3.1 Market Definition
Exhibit 09: Offerings of companies included in the market definition
3.2 Market segment analysis
Exhibit 10: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 11: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 12: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 13: Chart on US: Year-over-year growth 2022-2027 (%)
Exhibit 14: Data Table on US: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Sex reassignment surgery market in US 2017 - 2021
Exhibit 15: Historic Market Size ? Data Table on sex reassignment surgery market in US 2017 - 2021 ($ million)
Exhibit 18: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 19: Chart on Bargaining power of buyers ? Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 20: Bargaining power of suppliers ? Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 21: Threat of new entrants ? Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 22: Threat of substitutes ? Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 23: Threat of rivalry ? Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 24: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type
6.1 Market segments
Exhibit 25: Chart on Type - Market share 2022-2027 (%)
Exhibit 26: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 27: Chart on Comparison by Type
Exhibit 28: Data Table on Comparison by Type
6.3 Male to female - Market size and forecast 2022-2027
Exhibit 29: Chart on Male to female - Market size and forecast 2022-2027 ($ million)
Exhibit 30: Data Table on Male to female - Market size and forecast 2022-2027 ($ million)
Exhibit 31: Chart on Male to female - Year-over-year growth 2022-2027 (%)
Exhibit 32: Data Table on Male to female - Year-over-year growth 2022-2027 (%)
6.4 Female to male - Market size and forecast 2022-2027
Exhibit 33: Chart on Female to male - Market size and forecast 2022-2027 ($ million)
Exhibit 34: Data Table on Female to male - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Chart on Female to male - Year-over-year growth 2022-2027 (%)
Exhibit 36: Data Table on Female to male - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 37: Market opportunity by Type ($ million)
Exhibit 38: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 39: Chart on End-user - Market share 2022-2027 (%)
Exhibit 40: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 41: Chart on Comparison by End-user
Exhibit 42: Data Table on Comparison by End-user
7.3 Hospitals - Market size and forecast 2022-2027
Exhibit 43: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 45: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 46: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
7.4 Clinics - Market size and forecast 2022-2027
Exhibit 47: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Clinics - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by End-user
Exhibit 51: Market opportunity by End-user ($ million)
Exhibit 52: Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 53: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Drivers, Challenges, and Trends
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Exhibit 54: Impact of drivers and challenges in 2022 and 2027
9.4 Market trends
10 CompanyLandscape
10.1 Overview
10.2 Company landscape
Exhibit 55: Overview on Criticality of inputs and Factors of differentiation
10.3 Landscape disruption
Exhibit 56: Overview on factors of disruption
10.4 Industry risks
Exhibit 57: Impact of key risks on business
11 Company Analysis
11.1 Companies covered
Exhibit 58: Companies covered
11.2 Market positioning of companies
Exhibit 59: Matrix on company position and classification
11.3 Boston Medical Center
Exhibit 60: Boston Medical Center - Overview
Exhibit 61: Boston Medical Center - Product / Service
Exhibit 62: Boston Medical Center - Key offerings
11.4 Cedars Sinai Health System
Exhibit 63: Cedars Sinai Health System - Overview
Exhibit 64: Cedars Sinai Health System - Product / Service
Exhibit 65: Cedars Sinai Health System - Key offerings
11.5 CNY Cosmetic and Reconstructive Surgery
Exhibit 66: CNY Cosmetic and Reconstructive Surgery - Overview
Exhibit 67: CNY Cosmetic and Reconstructive Surgery - Product / Service
Exhibit 68: CNY Cosmetic and Reconstructive Surgery - Key offerings
11.6 Denver Health
Exhibit 69: Denver Health - Overview
Exhibit 70: Denver Health - Product / Service
Exhibit 71: Denver Health - Key offerings
11.7 Icahn School of Medicine at Mount Sinai
Exhibit 72: Icahn School of Medicine at Mount Sinai - Overview
Exhibit 73: Icahn School of Medicine at Mount Sinai - Product / Service
Exhibit 74: Icahn School of Medicine at Mount Sinai - Key offerings
11.8 Mass General Brigham Inc.
Exhibit 75: Mass General Brigham Inc. - Overview
Exhibit 76: Mass General Brigham Inc. - Product / Service
Exhibit 77: Mass General Brigham Inc. - Key offerings
11.9 Moein Surgical Arts
Exhibit 78: Moein Surgical Arts - Overview
Exhibit 79: Moein Surgical Arts - Product / Service
Exhibit 80: Moein Surgical Arts - Key offerings
11.10 Plastic Surgery Group of Rochester
Exhibit 81: Plastic Surgery Group of Rochester - Overview
Exhibit 82: Plastic Surgery Group of Rochester - Product / Service
Exhibit 83: Plastic Surgery Group of Rochester - Key offerings
11.11 Regents of the University of Michigan
Exhibit 84: Regents of the University of Michigan - Overview
Exhibit 85: Regents of the University of Michigan - Product / Service
Exhibit 86: Regents of the University of Michigan - Key offerings
11.12 Stanford University
Exhibit 87: Stanford University - Overview
Exhibit 88: Stanford University - Product / Service
Exhibit 89: Stanford University - Key offerings
11.13 The Cleveland Clinic Foundation
Exhibit 90: The Cleveland Clinic Foundation - Overview
Exhibit 91: The Cleveland Clinic Foundation - Product / Service
Exhibit 92: The Cleveland Clinic Foundation - Key offerings
11.14 The Johns Hopkins Health System Corp.
Exhibit 93: The Johns Hopkins Health System Corp. - Overview
Exhibit 94: The Johns Hopkins Health System Corp. - Product / Service
Exhibit 95: The Johns Hopkins Health System Corp. - Key offerings
11.15 The Regents of the University of California
Exhibit 96: The Regents of the University of California - Overview
Exhibit 97: The Regents of the University of California - Product / Service
Exhibit 98: The Regents of the University of California - Key offerings
11.16 The University of Utah
Exhibit 99: The University of Utah - Overview
Exhibit 100: The University of Utah - Product / Service
Exhibit 101: The University of Utah - Key offerings
11.17 Transgender Surgery Institute
Exhibit 102: Transgender Surgery Institute - Overview
Exhibit 103: Transgender Surgery Institute - Product / Service
Exhibit 104: Transgender Surgery Institute - Key offerings
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Exhibit 105: Inclusions checklist
Exhibit 106: Exclusions checklist
12.3 Currency conversion rates for US$
Exhibit 107: Currency conversion rates for US$
12.4 Research methodology
Exhibit 108: Research methodology
Exhibit 109: Validation techniques employed for market sizing
Exhibit 110: Information sources
12.5 List of abbreviations
Exhibit 111: List of abbreviations
About us Technavio is a leading global technology research and advisory company. their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. with over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. this growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community. Aspire Health experienced a data security incident that may have involved personal and...